Delivery Order SPE2DR25D2014-SPE2DR26FZ60Y
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $30,136.70 by the Defense Logistics Agency (DLA) on August 26, 2025, for the supply of REPATHA 140 mg/ml SureClick auto-injectors. This firm fixed-price delivery order, with an ultimate completion date of August 27, 2025, represents a competitively awarded contract with no set-aside designation. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $41,346.30 by the Defense Logistics Agency (DLA) on August 28, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors. This competitively awarded, firm fixed-price contract has an ultimate completion date of August 29, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order was issued with no set-aside designation, reflecting the open competition process...
- The Defense Logistics Agency awarded a $7,700.94 firm fixed-price delivery order to AmerisourceBergen Drug Corp for REPATHA 140 mg/mL SureClick auto-injector pharmaceutical product, with an ultimate completion date of September 18, 2025. This delivery order, issued on September 17, 2025, represents a non-competitive award under the company's existing indefinite delivery contract vehicle with DLA and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $35,697.41 by the Defense Logistics Agency for REPATHA 140 mg/ml SureClick auto-injector medication. The award was made on August 21, 2025, with an ultimate completion date of August 22, 2025, under a firm fixed-price delivery order structure with no set-aside designation. This competitive award is issued as a child order under AmerisourceBergen's larger Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp was awarded a delivery order on November 4, 2025, by the Defense Logistics Agency for the supply of Repatha 140 mg/ml SureClick auto-injectors. This is a competitively awarded, firm fixed-price delivery order with a ceiling value of $15,222.77 and an ultimate completion date of November 5, 2025. The product will be delivered to the company's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp was awarded a $7,085.19 delivery order by the Defense Logistics Agency (DLA) on May 30, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injector medication. This is a firm fixed price, non-competitive delivery order with an ultimate completion date of June 2, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp, a leading pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $16,340.28 by the Defense Logistics Agency on August 4, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injectors. The contract represents a firm fixed-price delivery order with no set-aside designation and is scheduled for completion by August 5, 2025. This award is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $35,772.20 on September 19, 2025, for the supply of REPATHA 140 mg/ml SureClick auto-injectors. This firm fixed-price delivery order, with an ultimate completion date of September 22, 2025, was issued without a set-aside designation and represents a competitively awarded procurement through the Defense Logistics Agency's Medical Supply Chain. The...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 21, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injector pharmaceutical product. The contract, valued at $7,567.40, carries a firm fixed price structure with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 22, 2025....
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,880.79 by the Defense Logistics Agency on November 3, 2025, with an ultimate completion date of November 4, 2025. The contract, issued under a firm fixed price arrangement, covers the supply of Repatha 140 mg/ml SureClick auto-injectors. This delivery order was competitively awarded with no set-aside designation and represents a child award...
- SPE2DR25D2014Indefinite Delivery Contract
- SPE2DR25D2014-SPE2DR26FZ60YDelivery Order
AmerisourceBergen Drug Corp has been awarded a delivery order valued at $8,646.68 by the Defense Logistics Agency for the supply of REPATHA 140 mg/ml SureClick auto-injectors, with an ultimate completion date of November 4, 2025. This non-set-aside contract employs firm fixed pricing and represents a child delivery order under the company's larger indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical products will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its primary operations as a major healthcare distributor serving federal medical procurement needs. This award leverages AmerisourceBergen Drug Corp's existing prime indefinite delivery vehicle with DLA Troop Support Medical (valued at $999,999,999 through December 2026), which provides comprehensive pharmaceutical support to military healthcare systems worldwide. The company's demonstrated capability in supplying specialty medications, including cardiovascular and other therapeutic products through competitive federal procurement processes, positions it as a critical vendor for Defense Health Agency and other government healthcare customers. AmerisourceBergen's portfolio of federal contract awards reflects consistent performance in delivering brand-name pharmaceuticals and medical devices across multiple therapeutic domains to support military and veteran healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.6k | 11/3/25 |